DocGo Inc.

DocGo Inc.DCGOEarnings & Financial Report

Nasdaq · Health Care · Services-Health Services

DocGo Inc. is a U.S.-headquartered mobile healthcare and on-demand medical service provider. It offers a range of solutions including in-home urgent care, diagnostic testing, telehealth consultations, and corporate wellness programs, serving individual patients, health systems, enterprise clients, and public sector organizations across North America.

Revenue

$164.9M

Gross Profit

N/A

Operating Profit

$10.1M

Net Profit

$6.5M

Gross Margin

N/A

Operating Margin

6.2%

Net Margin

4.0%

YoY Growth

31.4%

EPS

$0.06

DocGo Inc. Q2 FY2024 Financial Summary

DocGo Inc. reported revenue of $164.9M (up 31.4% YoY) for Q2 FY2024, with a net profit of $6.5M (up 386.0% YoY) (4.0% margin).

Key Financial Metrics

Total Revenue$164.9M
Net Profit$6.5M
Gross MarginN/A
Operating Margin6.2%
Report PeriodQ2 FY2024

Revenue Breakdown

DocGo Inc. Q2 FY2024 revenue of $164.9M breaks down across 2 segments, led by Mobile Health Services Segment at $116.7M (70.8% of total).

SegmentRevenue% of Total
Mobile Health Services Segment$116.7M70.8%
Transportation Services Segment$48.2M29.2%

DocGo Inc. Revenue by Segment — Quarterly Trend

DocGo Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Mobile Health Services Segment and Transportation Services Segment) has evolved quarter over quarter.

SegmentQ4 FY2025Q3 FY2025Q2 FY2025Q1 FY2025
Mobile Health Services Segment$24.8M$20.7M$30.8M$45.2M
Transportation Services Segment$50.2M$50.1M$49.6M$50.8M

DocGo Inc. Annual Revenue by Year

DocGo Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $322.2M).

YearAnnual Revenue
2025$322.2M
2024$616.6M
2023$624.3M
2022$440.5M

DocGo Inc. Quarterly Revenue & Net Profit History

DocGo Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q4 FY2025$74.9M-38.0%$-142.3M-190.0%
Q3 FY2025$70.8M-48.9%$-27.8M-39.2%
Q2 FY2025$80.4M-51.2%$-11.2M-13.9%
Q1 FY2025$96.0M-50.0%$-9.4M-9.8%
Q4 FY2024$120.8M-39.4%$-7.6M-6.3%
Q3 FY2024$138.7M-25.7%$5.5M4.0%
Q2 FY2024$164.9M+31.4%$6.5M4.0%
Q1 FY2024$192.1M+70.0%$11.2M5.8%

Income Statement

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Revenue$192.1M$164.9M$138.7M$120.8M$96.0M$80.4M$70.8M$74.9M
YoY Growth70.0%31.4%-25.7%-39.4%-50.0%-51.2%-48.9%-38.0%

Balance Sheet

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Assets$490.7M$488.2M$493.9M$455.6M$430.8M$408.3M$353.8M$217.1M
Liabilities$175.6M$170.2M$169.0M$140.4M$128.9M$120.5M$93.1M$91.2M
Equity$311.3M$315.2M$325.2M$320.9M$309.3M$297.3M$270.5M$144.0M

Cash Flow

Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
Operating CF$-10.6M$36.9M$31.1M$12.7M$9.7M$33.6M$1.7M$-10.5M